AMES, Iowa, July 10, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation  (NASDAQ: NLNK ) today announced that it will release its second quarter 2018 financial results on Tuesday, July 31, 2018. The company has scheduled a conference call for 4:30 PM ET the same day to discuss these results and to give an update on its clinical development, corporate strategy and cash guidance.

NewLink Genetics' senior management team will host the conference call, which will be open to all listeners. There will also be a question and answer session following the prepared remarks.

Access to the live conference call is available by dialing (855) 469-0612 (U.S.) or (484) 756-4268 (international) five minutes prior to the start of the call. The conference call will be webcast live and a link can be accessed through the NewLink Genetics website at  https://edge.media-server.com/m6/p/98cc7df2 . A replay of the call will be available for two weeks from the date of the call and can be accessed by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (international) and using the passcode 4478527.

About NewLink Genetics Corporation

NewLink Genetics is a clinical stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' IDO pathway inhibitors are designed to harness multiple components of the immune system to combat cancer. For more information, please visit http://www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics .

Investor Contact:

Lisa Miller Director of Investor Relations NewLink Genetics 515-598-2555 lmiller@linkp.com

Media Contact:

Sharon Correia VP, Integrated Communications LaVoieHealthScience 617-374-8800, ext. 105 scorreia@lavoiehealthscience.com